For the millions of people affected by dementia and Parkinson’s, better treatments can’t come soon enough. Current options ...

The National Institute for Health and Care Excellence (NICE) has today issued final decisions on lecanemab and donanemab, ...

This week the Government revealed its Spending Review - we dive into what the settlement means for progress on dementia.

Prof Sir John Hardy, Vice President of Alzheimer’s Research UK, outlines how the UK can continue to drive progress towards a ...

The following questions will help us to understand how well our information worked for you, what difference it’s made and what kind of information you’d like to see in the future.

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Find out the 10 most important facts and statistics about dementia and dementia research. Click on each fact for more information. 1. Dementia is not a disease itself. Expand The word ‘dementia’ is a ...

Join us on Monday 24 February 2025, for a day dedicated to supporting early career researchers in the dementia field. Sessions start at 11am. This event is designed to provide you with the knowledge, ...

Our brains control everything we think, feel, remember and do. There are diseases that stop a person’s brain from working properly. When a person has one of these diseases, they may have problems with ...

Researchers at the Drug Discovery Alliance (DDA) have developed several lead molecules that could help restore the function of the blood brain barrier. One of them has led to a patent application. The ...

Vascular dementia occurs when blood vessels that deliver blood to the brain become damaged. Our blood contains oxygen and nutrients that help the brain cells to work properly. When blood vessels are ...